Article Information
History
- February 25, 2020.
Article Versions
- You are currently viewing Version 1 of this article (February 25, 2020 - 01:41).
- Version 2 (May 13, 2020 - 22:19).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- P. Soblechero-Martín1,
- E. Albiasu-Arteta1,
- A. Anton-Martinez1,
- I. Garcia-Jimenez1,
- G. González-Iglesias1,
- I. Larrañaga-Aiestaran1,
- A. López-Martinez1,
- J. Poyatos-García2,
- E. Ruiz-Del-Yerro1,
- F. Gonzalez3 and
- V. Arechavala-Gomeza1,4,*
- 1Neuromuscular Disorders, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain
- 2La Fe Health Research Institute, Hospital La Fe, Valencia, Spain
- 3Pluripotent Stem Cells and Activation of Endogenous Tissue Programs for Organ Regeneration (PR Lab), Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain
- 4Ikerbasque, Basque Foundation for Science, Bilbao, Spain
- ↵*Address for correspondence:
Prof. Virginia Arechavala-Gomeza, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, 48903, Spain, Phone: +34 946007967, E-mail: virginia.arechavalagomeza{at}osakidetza.eus